AstraZeneca and Sanofi’s Breakthrough RSV Infant Shots Approved in China

AstraZeneca and Sanofi’s Breakthrough RSV Infant Shots Approved in China

In a significant development for infant healthcare, AstraZeneca and Sanofi have announced the approval of their respiratory syncytial virus (RSV)…